MEDIA

---

In recognition of his work for equity and inclusion in health for all and his commitment to advancing technology for humanity, our CEO, Dimitrios Kalogeropoulos is nominated and appointed Global AI Ambassador, a prestigious and challenging role with the Global AI Ambassador Program inspired and delivered by the SwissCognitive, World-Leading AI Network. In this role, Dimitris joins forces with a network of distinguished Global AI Ambassadors from six continents and 18 countries, with the mission to combine human-AI intelligence, creating high-performing businesses with equitable economic advancement for global societies.

#ghdif.org

Telehealth’s Role Enabling Sustainable Innovation and Circular Economies in Health

Kalogeropoulos, PhD, D. ., & Barach, BSC, MD, MPH, P. (2023). Telehealth’s Role Enabling Sustainable Innovation and Circular Economies in Health. Telehealth and Medicine Today, 8(1).
 

Digital health interventions including telehealth support an increasingly broad range of improvement goals for prevention and treatment. Limitations obstructing the many digital benefits of telehealth from reaching their full potential include lack of robust usability and user centered design, regulatory policy paradigms, lack of adequate high-quality evidence and methodologies to evaluate the performance generalization and clinical robustness. Health innovation is explored in the context of different value systems and a solution is proposed to the fundamental limitations arising in the data value system, an approach to a new telehealth paradigm and incorporated intervention designs which combine clinical innovation with innovation in data resource development. Machine learning and artificial intelligence have the potential to enable circular economies for digital and health innovation, in which sustainable solutions can be offered within a data-enabled collaborative and shared digital ecosystem. Alignment of industry standards, adjustments to regulatory policies, and embracing new governance models for telehealth-based innovation are essential for this new approach to health innovation scaling, clinical adoption and social innovation. Given the trends in technological advances in the past decades, it is likely that healthcare reliance on telehealth will continue to grow.

#ghdif.org

 Artificial intelligence is revolutionising many aspects of our lives. Although it entered clinical practice only in recent years, its contribution to clinical research and patient data handling has a growing impact in the development of precision medicine. A panel of digital science and oncology experts discussed the advances and challenges of AI within this context in the third webinar of the SPCC Artificial Intelligence in Cancer Care 2022 series, which took place on 15 December 2022. Our Chief Executive, Dr. Dimitrios Kalogeropoulos was in that panel.

#ghdif.org

 With the focus on accuracy, ethics, and bias in AI algorithms, we cannot lose sight of the need for more validated data. With hard-hitting insights and references, is the right question being asked: is AI good for medicine or is medicine right for AI?

Dr. Dimitrios Kalogeropoulos, Chief Executive Global Health & Digital Innovation Foundation and Senior Independent Consultant for organizations like the World Health Organization (WHO) and the United Nations International Children’s Emergency Fund (UNICEF), looks to the data for answers with our host, Maria Palombini.

#ghdif_org